157286-81-2 Usage
Uses
Used in Medicinal Chemistry:
4-CHLORO-2,5-DIMETHYL-7-(2,4,6-TRIMETHYLPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDINE is used as a starting material for the synthesis of pharmaceutical compounds with potential biological activities. Its unique structure and functional groups make it a promising candidate for the development of new drugs with therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, 4-CHLORO-2,5-DIMETHYL-7-(2,4,6-TRIMETHYLPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDINE can be employed as a building block or intermediate in the preparation of more complex organic molecules. Its reactivity and structural features allow for further functionalization and modification, enabling the synthesis of a wide range of organic compounds.
Used in Materials Science:
4-CHLORO-2,5-DIMETHYL-7-(2,4,6-TRIMETHYLPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDINE may also have applications in materials science, where its unique chemical and physical properties can be utilized to develop new materials with specific characteristics. These materials could have potential uses in various industries, such as electronics, coatings, or advanced materials for specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 157286-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,2,8 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 157286-81:
(8*1)+(7*5)+(6*7)+(5*2)+(4*8)+(3*6)+(2*8)+(1*1)=162
162 % 10 = 2
So 157286-81-2 is a valid CAS Registry Number.
157286-81-2Relevant academic research and scientific papers
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3- d]pyrimidine: A centrally active corticotropin-releasing factor1 receptor antagonist
Chen, Yuhpyng L.,Mansbach, Robert S.,Winter, Steven M.,Brooks, Elizabeth,Collins, Judith,Corman, Michael L.,Dunaiskis, Audrey R.,Faraci, W. Stephen,Gallaschun, Randall J.,Schmidt, Anne,Schulz, David W.
, p. 1749 - 1754 (2007/10/03)
The syntheses of a centrally active nonpeptide CRF1 receptor antagonist 2, butylethyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3- d]pyrimidin-4-yl]amine (CP-154,526), and its analogs 11-14 and [3H]-2 are reported. The in v
